These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 14511240)

  • 1. Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.
    Ahmad SR; Lidington EA; Ohta R; Okada N; Robson MG; Davies KA; Leitges M; Harris CL; Haskard DO; Mason JC
    Immunology; 2003 Oct; 110(2):258-68. PubMed ID: 14511240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury.
    Lidington EA; Haskard DO; Mason JC
    Blood; 2000 Oct; 96(8):2784-92. PubMed ID: 11023512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC; Lidington EA; Ahmad SR; Haskard DO
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
    Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
    Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay-accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of endothelial protein kinase C.
    Hindmarsh EJ; Marks RM
    Eur J Immunol; 1998 Mar; 28(3):1052-62. PubMed ID: 9541601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decay-accelerating factor induction on vascular endothelium by vascular endothelial growth factor (VEGF) is mediated via a VEGF receptor-2 (VEGF-R2)- and protein kinase C-alpha/epsilon (PKCalpha/epsilon)-dependent cytoprotective signaling pathway and is inhibited by cyclosporin A.
    Mason JC; Steinberg R; Lidington EA; Kinderlerer AR; Ohba M; Haskard DO
    J Biol Chem; 2004 Oct; 279(40):41611-8. PubMed ID: 15284224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
    Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
    J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
    Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
    Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin.
    Kinderlerer AR; Pombo Gregoire I; Hamdulay SS; Ali F; Steinberg R; Silva G; Ali N; Wang B; Haskard DO; Soares MP; Mason JC
    Blood; 2009 Feb; 113(7):1598-607. PubMed ID: 19036700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Oxygenase 1 Up-Regulates Glomerular Decay Accelerating Factor Expression and Minimizes Complement Deposition and Injury.
    Detsika MG; Duann P; Atsaves V; Papalois A; Lianos EA
    Am J Pathol; 2016 Nov; 186(11):2833-2845. PubMed ID: 27662796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.
    Miwa T; Sun X; Ohta R; Okada N; Harris CL; Morgan BP; Song WC
    Immunology; 2001 Oct; 104(2):207-14. PubMed ID: 11683961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells.
    Andoh A; Fujiyama Y; Sumiyoshi K; Sakumoto H; Okabe H; Bamba T
    Immunology; 1997 Mar; 90(3):358-63. PubMed ID: 9155641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack.
    Barata L; Miwa T; Sato S; Kim D; Mohammed I; Song WC
    J Immunol; 2013 Mar; 190(6):2886-95. PubMed ID: 23390291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
    Sun X; Funk CD; Deng C; Sahu A; Lambris JD; Song WC
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):628-33. PubMed ID: 9892684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.